title: Beneficial effects of taurolidine in experimental pancreatitis.
abstract: Taurolidine has potent antiendotoxin and antimicrobial effects in vitro. This study assessed the effect of taurolidine in a well-described model of acute pancreatitis. Ninety-five male Wistar rats (250 g) were studied. Pancreatitis was induced by intraductal injection of 50 microliters of a 4% sodium taurocholate solution at a pressure of 25 cm water. Animals were randomly allocated to 1 of 10 groups: 4 groups were used to characterize the model and there were 6 treatment groups. Taurolidine (100 mg/kg) or saline was administered intravenously at Time 1, 4 hr, or 4 and 24 hr following induction of pancreatitis. Serum amylase, endotoxin levels, and blood cultures were assessed at 4 and 24 hr. Survival was documented at 1 week. Serum amylase levels were elevated in animals in whom acute pancreatitis was induced; however, there was no difference in serum amylase between animals treated with taurolidine and those treated with saline. Positive blood cultures were more numerous in saline-treated groups. Treatment with taurolidine was associated with significantly (P < 0.01) lower endotoxin levels (14 +/- 8 pg/ml) compared with saline-treated animals (350 +/- 87 pg/ml). Taurolidine administration significantly improved survival compared with controls, when given at 4, 24, and 4/24 hr postinduction of pancreatitis (P < 0.05). Taurolidine was beneficial in this model of acute pancreatitis.
authors.affiliation: Department of Surgery, Meath Hospital, Dublin, Ireland.
authors.forename: H P
authors.initials: HP
authors.lastname: Redmond
authors.forename: A L
authors.initials: AL
authors.lastname: Leahy
authors.forename: J A
authors.initials: JA
authors.lastname: Carey
authors.forename: A
authors.initials: A
authors.lastname: Darzi
authors.forename: B
authors.initials: B
authors.lastname: Maxwell
authors.forename: F B
authors.initials: FB
authors.lastname: Keane
authors.forename: W A
authors.initials: WA
authors.lastname: Tanner
mesh_terms: D000208:Acute Disease; D000681:Amylases / Q000097:blood; D000818:Animals; D008297:Male; D010195:Pancreatitis / Q000188:drug therapy*; D051381:Rats; D017208:Rats, Wistar; D013654:Taurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013829:Thiadiazines / Q000627:therapeutic use*
chemical_list: D013829:Thiadiazines; D013654:Taurine; C012566:taurolidine; D000681:Amylases